Moreover, the 36-month beta value for NTRB is 0.41. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NTRB is 5.56M and currently, short sellers hold a 1.08% of that float. On September 24, 2024, NTRB’s average trading volume was 35.96K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NTRB) stock’s latest price update
The stock of Nutriband Inc (NASDAQ: NTRB) has increased by 8.91 when compared to last closing price of 6.17.Despite this, the company has seen a gain of 48.67% in its stock price over the last five trading days. accesswire.com reported 2024-09-20 that Nutriband signs trademark licensing agreement for Bitrex® brand denatonium benzoate, the most bitter substance in the world, as an aversive agent for its Aversa™ Fentanyl abuse deterrent fentanyl transdermal patch Nutriband abuse-deterrent transdermal technology consists of a proprietary aversive agent coating that employs taste aversion to deter the oral abuse of and accidental exposure to transdermal opioid and stimulant patch products ORLANDO, FL / ACCESSWIRE / September 20, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has signed a trademark licensing agreement for the use of Bitrex® brand denatonium benzoate as an aversive agent in its lead product, AVERSA™ Fentanyl, an abuse deterrent fentanyl patch. Nutriband’s AVERSA™ abuse-deterrent technology can be utilized to incorporate aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential.
NTRB’s Market Performance
NTRB’s stock has risen by 48.67% in the past week, with a monthly rise of 14.87% and a quarterly rise of 24.68%. The volatility ratio for the week is 20.11% while the volatility levels for the last 30 days are 14.28% for Nutriband Inc The simple moving average for the past 20 days is 42.30% for NTRB’s stock, with a 61.73% simple moving average for the past 200 days.
NTRB Trading at 17.49% from the 50-Day Moving Average
After a stumble in the market that brought NTRB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -29.96% of loss for the given period.
Volatility was left at 14.28%, however, over the last 30 days, the volatility rate increased by 20.11%, as shares surge +24.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.60% upper at present.
During the last 5 trading sessions, NTRB rose by +48.67%, which changed the moving average for the period of 200-days by +158.46% in comparison to the 20-day moving average, which settled at $4.79. In addition, Nutriband Inc saw 189.66% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NTRB
Current profitability levels for the company are sitting at:
- -3.51 for the present operating margin
- 0.32 for the gross margin
The net margin for Nutriband Inc stands at -4.02. The total capital return value is set at -0.51. Equity return is now at value -74.87, with -61.64 for asset returns.
Based on Nutriband Inc (NTRB), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -19.41. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -82.14.
Currently, EBITDA for the company is -4.58 million with net debt to EBITDA at 1.08. When we switch over and look at the enterprise to sales, we see a ratio of 37.71. The receivables turnover for the company is 26.52for trailing twelve months and the total asset turnover is 0.13. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.57.
Conclusion
To wrap up, the performance of Nutriband Inc (NTRB) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
